The Statin Paradox: Why This Drug Doesn't Help Most Patients
Mark Hyman and an unnamed cardiologist guest question who actually benefits from statins. They argue that heart risk tracks more with insulin resistance, triglycerides and HDL than with LDL alone.
The gist
-
Hyman cites a study of 231,000 heart attack patients where 75% had LDL under 130, but average HDL was 39 and triglycerides 160.
-
The cardiologist guest says a David Diamond analysis found no statin benefit in trial patients with normal triglycerides and HDL, even after a heart attack.
-
The guest says at least 50% of patients stop statins within a couple of years, and he sees side effects like muscle pain in 20 to 50%.
-
Both agree some people react badly to saturated fat, and the guest cites Ron Krauss finding lipid effects above 18% of total calories.
-
The guest warns that unneeded tests and LDL fears cause anxiety, while Hyman prefers more data, like catching insulin rising above 10 early.
Mark, Joe, Andrew and Rhonda agree on 43 things
See what they all use, in their own words. Paid ads are left out.
See what they all swear by Or pick your own peopleAlso mentioned
7:41
PCSK9 inhibitors
· "there's a use for the PCSK9 inhibitors there's a use for the new CTP drugs that are coming out there are..."
7:43
CTP drugs
· "there's a use for the PCSK9 inhibitors there's a use for the new CTP drugs that are coming out there are..."
9:25
Carnivore diet
· "I've seen for example a patient on a carnivore diet who actually had something like that and when they..."
◎
Related episodes
Episodes covering similar topics
Sleep Apnea: Why CPAP Isn't Fixing the Real Problem (This Does!)
cardiovascular health
It's Not Cholesterol. Inflammation Is What's Actually Causing Heart Disease
cardiovascular health
Lower Cholesterol in 10 Days: Stop Treating the Symptom! | DO THIS Instead
cardiovascular health
More from Mark Hyman, MD